IRS Rule On Flex-Spending Accounts A Boon For Chronic-Use OTCs, Switches

Schering-Plough's Claritin and Procter & Gamble's Prilosec OTC are likely to be major beneficiaries of an IRS ruling that nonprescription drugs can be covered by employee health flexible spending arrangements